|
|
| MRD / Regn No. |
: 4629 |
Date |
: 03/07/2026 |
| Patient Name |
: Bhaswati Biswas |
Age & Gender |
: 57 Yrs. / Female |
| Contact No. |
: 8787746549 |
UHID |
: |
| Ht / Wt / BMI |
: 157 / 63106 / 25601.85 |
BP S / BP D |
: 65 / 86 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DIABETES (31/Jan/2004) | HYPOTHYROIDISM (31/Jan/2024) | HYPERTENSION (31/Jan/2024) | |
| Salient Investigations |
: |
FASTING PLASMA GLUCOSE (FPG): 205 mg/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 9.8 % | MICROALBUMIN CREATININE RATIO: 11.1 mcg/mg |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TABLET THYROXINE 150 MCG
THYRONORM 150 MCG
Medicine For HYPOTHYROIDISM |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
| MUST BE TAKEN ON AN EMPTY STOMACH. COFFEE TEA OR BREAKFAST MUST BE TAKEN ONLY AFTER 30 MINUTES. OTHER DRUGS CAN INTERFERE WITH THE ABSORPTION OF THYROXINE | |
|
2 |
TABLET ROSUVASTATIN 20 MG
STATEZE R 20 |
PO |
0-0-1 |
BEFORE DINNER
|
TILL NEXT VISIT |
|
|
3 |
ANTIHYPERGLYCEMIC GLICLAZIDE 60 MG + METFORMIN 500 MG
SECGLY M XR |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
4 |
ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG
APDA 10 MG |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
5 |
INJECTION GLARGINE (INJ U100)
LANTUS
Medicine For GLUCOSE CONTROL |
SQ |
0-0-20 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 03/Jan/2027 |
| Tests Suggested For Next Visit |
: HBA1C-HPLC METHOD,UACR:SPOT SAMPLE,ECG (ALL LEADS) |
| |
|
| |
|
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal /
54020
This is a Computer generated Prescription |
Powered By:  |